XELODA 500 (Xeloda 500 mg)

Generic Name: capecitabine

Pill imprint XELODA 500 has been identified as Xeloda 500 mg.

Xeloda is used in the treatment of colorectal cancer; breast cancer, metastatic; pancreatic cancer; breast cancer; non-small cell lung cancer (and more), and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Xeloda 500 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for XELODA 500

Xeloda 500 mg XELODA 500 Front
Xeloda 500 mg XELODA 500 Back
Xeloda 500 mg XELODA 500
Xeloda 500 mg XELODA 500
Xeloda
Generic Name:
capecitabine
Imprint:
XELODA
500
Strength:
500 mg
Color:
Pink
Size:
11.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roche Laboratories
National Drug Code (NDC):
00004-1101
Inactive Ingredients:
croscarmellose sodium
hypromellose 2208 (15000 mPa.s)
microcrystalline cellulose
magnesium stearate
water
magnesium silicate
titanium dioxide
ferric oxide red
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5260 Physicians Total Care Inc (repackager)
68258-9036 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)